Dr. Purohit-Sheth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Wisconsin Ave
Bldg 17
Bethesda, MD 20889Phone+1 301-295-2510Fax+1 301-319-8299
Education & Training
National Capital ConsortiumFellowship, Allergy and Immunology, 1997 - 1999
Naval Medical Center (Portsmouth)Residency, Internal Medicine, 1994 - 1996
Eastern Virginia Medical SchoolClass of 1994
Certifications & Licensure
VA State Medical License 1996 - 2026- American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- 12 citationsFDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.Najat Bouchkouj, Xue Lin, Xiaofei Wang, Donna Przepiorka, Zhenzhen Xu
The Oncologist. 2022-10-01 - 24 citationsClinical Development of Gene Therapies: The First Three Decades and Counting.Larissa Lapteva, Tejashri Purohit-Sheth, Mercedes A. Serabian, Raj K. Puri
Molecular Therapy. Methods & Clinical Development. 2020-10-10 - 3 citationsFDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma.Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, Cong Wang, Tianjiao Dai
The Oncologist. 2022-07-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
